Forty-four years ago, Nadrian Seeman published his groundbreaking ideas on using DNA as a structural material, expanding ...

Cleveland oncologist Alberto Montero explains what the screening guidelines actually cover, why most patients have no ge ...

Artificial Intelligence (AI) is rapidly advancing—and with it, the promise of solving some of academia's toughest problems.

Maynooth University researchers built a scaffolded DNA computer that uses molecular reactions to perform arithmetic and ...

OpenSpec, a lightweight framework for sharing specifications with AI coding agentsPublished: 2026-09-16T23:06:39+00:00URL: IT/InternetTags: OpenSpec, Specification Management, AI Coding, Development ...

A monthly GLP-1 drug has been a long-running ambition at Novo. A few months before the Ascendis deal in 2024, the Danish pharma scrapped a once-monthly dual GLP-1/GIP receptor agonist over ...

Most pharmaceutical companies begin drug discovery with a familiar question: What disease are we trying to treat? Research ...

Two years after I began investigating connected-vehicle privacy. A new study finds that automakers' privacy policies have grown longer, more complicated and further beyond the reading level of ...

Mas-Related GPCR X4 (MRGPRX4) is a sensory neuron-restricted receptor for cholestatic itch. Here, we identify MRGPRX4 as an unexpected melanoma driver. MRGPRX4 is upregulated in melanoma and is ...

Cell And Gene Therapies For Rare Disorders Poised For Breakthrough Growth Through 2036, Fueled By Innovation, Expanding Pipelines And Unmet Patient Needs. Advances in gene editing, vectors and ...

September 15, 2026) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics"), a leader in the development of diagnostic and prognostic tests based on three-dimensional ...

From tracking koalas to mapping forests, cruising over coastlines and crops, CSIRO's growing drone fleet is helping ...